Free Trial

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 1 of 15

 
 

Fresenius Medical Care (NYSE:FMS)

Consensus Rating
Hold
Rating Score
2.2
Ratings Breakdown
2 Buy Ratings, 2 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$24.30 (14.0% Upside)

About Fresenius Medical Care

Fresenius Medical Care logoFresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/6/2024Berenberg BankInitiated CoverageBuy$25.60
10/7/2024Truist FinancialBoost Price TargetHold ➝ Hold$22.00 ➝ $23.00
7/31/2024Truist FinancialLower Price TargetHold ➝ Hold$24.00 ➝ $22.00
5/15/2024Truist FinancialBoost Price TargetHold ➝ Hold$21.00 ➝ $24.00
1/8/2024Morgan StanleyDowngradeEqual Weight ➝ Underweight
11/24/2023HSBCUpgradeReduce ➝ Hold
11/17/2023Societe GeneraleUpgradeHold ➝ Buy
10/11/2023Truist FinancialLower Price TargetHold ➝ Hold$28.00 ➝ $24.00
9/13/2023UBS GroupUpgradeSell ➝ Neutral
8/16/2023Morgan StanleyBoost Price Target€40.50
 

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Claim your FREE 2024 Gold Guide